Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Dear Editor,
We read with great interest the article of Bendib et al. published in Critical Care [1], in which they systematically assessed inflammatory mediators in pneumonia-related ARDS, both in airways and blood compartments. The authors observed a lung compartmentalization of inflammatory mediators, with important heterogeneity in the bronchoalveolar lavage fluid-to-serum concentration ratios across the mediators screened. The concept of compartmentalization of inflammation has already been formulated in pneumonia [2], and issues raised by assessing lung inflammation using blood inflammatory markers has also been highlighted, as well as the subsequent limitations of these biomarkers for bedside management [3]. However, we believe that it is critical to examine it further in ARDS, in this COVID-19 era. Indeed, since the beginning of the pandemic, most of the studies exploring immune dysregulation during COVID-19 were nevertheless based on data obtained only from blood, not because this is the most relevant compartment, but because it is the most easily accessible.
In complement to the work of Bendib et al., we evaluated coincident inflammatory mediators in blood and respiratory fluids (endotracheal aspirates [ETA]) of 21 critically ill COVID-19 patients with ARDS requiring mechanical ventilation, within 48 h of their admission in ICU. As observed by Bendib et al., we found an increased ETA-to-blood concentration ratio for IL-8, the cytokine for which concentration was the most compartmentalized to the lung. However, in our COVID-19 ARDS cohort, the median (quartile 1; quartile 3) ratio was highly elevated: 7355 (1959; 22433), compared to 20 in the study of Bendib et al. Moreover, ETA to blood concentration ratios of IL-1RA, IL-6, IFN-γ, TNF-α and CXL10 were also highly elevated (Fig. 1), at a higher level than those reported by Bendib et al. for ARDS without shock. Thus, during COVID-19-driven ARDS -and even compared to non-COVID-pneumonia-related ARDS- inflammation appears highly compartmentalized to the lungs. These results are in line with publications reporting relatively low levels of systemic inflammatory mediators compared to other conditions requiring ICU [4, 5]. Taken together, these data challenge the concept of “systemic cytokine-storm” that has been employed to describe immune dysregulation during severe COVID-19. Consequently, in our quest of identifying reliable biomarker in pneumonia-induced ARDS -whether COVID or not-, lungs should not be excluded.
Fig. 1
Endotracheal aspiration (ETA)-to-serum concentration ratio of inflammatory biomarkers in COVID-19-related ARDS. Inflammatory mediators (IL-1Ra, IL-6, IL-8, IL-10, CXCL-10, IFN-γ, TNF-α) were measured in blood (serum) and supernatants of endotracheal aspirations with the Bio-Plex Pro Human cytokines panel (Bio-Rad) in a multiplex fluorescent bead assay (Luminex), according to the manufacturer’s instructions. The density ratio of endotracheal aspiration (g/mL) was 1:1. Circles and bars represent median values and interquartile range respectively
×
Anzeige
Authors’ response
Inès Bendib5, 6 and Nicolas de Prost5, 6
(5)
Service de Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, 51, Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil Cedex, France
(6)
Groupe de Recherche Clinique CARMAS, Faculté de Santé de Créteil, Université Paris Est Créteil, 94010 Créteil Cedex, France
Interleukin-8 is highly compartmentalized to the lungs in COVID-19 and non-COVID-19 ARDS
We thank Jouan et al. for their letter related to our recently published article [1]. Although serum biomarkers can depict specific profiles in patients with ARDS associated with COVID-19 and other diseases [6], the degree of cytokine release is markedly lower in critically ill COVID-19 than in other disorders associated with elevated cytokines (e.g., non-COVID-19 ARDS, sepsis, CAR-T cell therapy) [7]. Assessing the production of lung borne cytokines might thus be particularly relevant in COVID-19 patients. Consistent with our results in non-COVID-19 ARDS patients, Jouan et al. showed in patients with severe SARS-CoV-2 infection that the highest endotracheal aspirates (ETA) to blood concentration ratio was observed for interleukin-8 (IL-8). The authors pointed out some differences regarding the magnitude of the concentration gradient they measured (median value of the ETA to blood ratio of IL-8: 7355) and ours, which included only non-COVID-19 patients with pneumonia-associated ARDS (median value of the broncho-alveolar lavage (BAL) to serum ratio of IL-8: 21). Such magnitude difference might be due to the following factors: (1) a dilution of BAL fluid samples; (2) differences in IL-8 concentrations in proximal vs. distal airways and hypothetically, (3) higher IL-8 lung to blood concentration ratios in COVID-19 than in non-COVID-19 patients. ETA to blood concentration ratios of other cytokines, including interleukin-6 were also highly elevated in COVID-19 patients in the letter of Jouan et al. However, the clinical implications of these findings need to be investigated. Further studies will be needed to assess whether measuring lung to blood concentration ratios of selected biomarkers could help target patients most likely to benefit from immunomodulating drugs targeting cytokine pathways [8].
Acknowledgements
Not applicable.
Ethics approval and consent to participate
All patients or their next of kin gave consent for participation in the study cited in this research letter. This work was part of an ongoing study exploring immune response during community-acquired pneumonia (ClinicalTrial.gov identifier: NCT03379207). The study was approved by the ethic committee “Comité de Protection de Personnes Ile-de-France 8” under the agreement number 2017-A01841-52, in accordance with the national laws.
Consent for publication
Not applicable.
Anzeige
Competing interests
No competing interests to declare.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.
Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.
Zwar scheint es laut einer Studie aus den USA und Kanada bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.
Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.
Update AINS
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
